Search Results - Yoshiki Terada
- Showing 1 - 2 results of 2
-
1
Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednis... by Hirohisa Nakamae, Kei Tsumura, Yoshiki Terada, Takahiko Nakane, Mika Nakamae, Kensuke Ohta, Takahisa Yamane, Masayuki Hino
Published 2005Artigo -
2
Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma by Yoshiki Terada, Hirohisa Nakamae, Ran Aimoto, Hiroshi Kanashima, Erina Sakamoto, Mizuki Aimoto, Eri Inoue, Hideo Koh, Takahiko Nakane, Yasunobu Takeoka, Masahiko Ohsawa, Ki‐Ryang Koh, Takahisa Yamane, Yoshitaka Nakao, Kensuke Ohta, Atsuko Mugitani, Hirofumi Teshima, Masayuki Hino
Published 2009Artigo
Search Tools:
Related Subjects
CHOP
Chemotherapy
Cyclophosphamide
Internal medicine
Medicine
Vincristine
Angiotensin II
Angiotensin receptor
Blood pressure
Cardiology
Cardiotoxicity
Confidence interval
Diffuse large B-cell lymphoma
Doxorubicin
Hazard ratio
Lymphoma
Oncology
Pharmacology
Prednisolone
Proportional hazards model
Rituximab
Valsartan